Henry Schein Inc (HSIC)

Price$77.21

Favorite Metrics

Price vs S&P 500 (26W)15.62%

Price vs S&P 500 (4W)0.06%

Market Capitalization$8.87B

P/E Ratio (Annual)22.28x

All Metrics

P/CF (Annual)12.45x

Book Value / Share (Quarterly)$28.03

P/TBV (Annual)4.04x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)1.40%

Cash Flow / Share (Quarterly)$4.50

Price vs S&P 500 (YTD)-0.21%

Gross Margin (TTM)31.14%

Net Profit Margin (TTM)3.02%

EPS (TTM)$3.27

10-Day Avg Trading Volume0.94M

EPS Excl Extra (TTM)$3.27

Revenue Growth (5Y)5.43%

EPS (Annual)$3.27

ROI (Annual)6.27%

Gross Margin (Annual)31.14%

Net Profit Margin (5Y Avg)3.76%

Cash / Share (Quarterly)$1.35

P/E Basic Excl Extra (TTM)22.28x

Revenue Growth QoQ (YoY)7.71%

EPS Growth (5Y)2.97%

P/E Normalized (Annual)22.28x

ROA (Last FY)3.55%

Revenue Growth TTM (YoY)4.03%

EBITD / Share (TTM)$7.50

ROE (5Y Avg)13.83%

Operating Margin (TTM)4.95%

Cash Flow / Share (Annual)$4.50

P/B Ratio2.73x

P/B Ratio (Quarterly)2.77x

Net Income / Employee (Annual)$0

EV / Revenue (TTM)0.90x

Net Interest Coverage (TTM)5.56x

ROA (TTM)3.64%

EPS Growth QoQ (YoY)14.05%

EV / EBITDA (TTM)12.94x

EPS Incl Extra (Annual)$3.27

Current Ratio (Annual)1.38x

Quick Ratio (Quarterly)0.56x

3-Month Avg Trading Volume1.28M

52-Week Price Return18.00%

EV / Free Cash Flow (Annual)22.68x

P/E Incl Extra (TTM)22.28x

Revenue / Employee (TTM)$1

Tangible BV / Share (Quarterly)$19.24

P/S Ratio (Annual)0.67x

Asset Turnover (Annual)1.18x

52-Week High$89.29

Operating Margin (5Y Avg)5.52%

EPS Excl Extra (Annual)$3.27

CapEx CAGR (5Y)31.38%

Tangible BV CAGR (5Y)-4.94%

26-Week Price Return19.60%

Quick Ratio (Annual)0.56x

13-Week Price Return1.69%

Total Debt / Equity (Annual)0.96x

Current Ratio (Quarterly)1.38x

Enterprise Value$11,818.201

Revenue / Share Growth (5Y)8.89%

Asset Turnover (TTM)1.21x

Book Value / Share Growth (5Y)3.59%

Revenue / Employee (Annual)$1

Inventory Turnover (Annual)4.76x

Pretax Margin (Annual)4.04%

Cash / Share (Annual)$1.35

3-Month Return Std Dev27.53%

Gross Margin (5Y Avg)30.80%

Net Income / Employee (TTM)$0

EBITDA CAGR (5Y)5.62%

EBITDA Interim CAGR (5Y)0.68%

ROE (Last FY)12.27%

Net Interest Coverage (Annual)5.56x

EPS Basic Excl Extra (Annual)$3.27

P/FCF (TTM)16.83x

Receivables Turnover (TTM)8.42x

EV / Free Cash Flow (TTM)22.68x

Total Debt / Equity (Quarterly)0.96x

EPS Incl Extra (TTM)$3.27

Receivables Turnover (Annual)8.42x

ROI (TTM)6.25%

P/S Ratio (TTM)0.67x

Pretax Margin (5Y Avg)4.98%

Revenue / Share (Annual)$108.32

Tangible BV / Share (Annual)$19.24

Forward P/E14.53x

Free OCF CAGR (5Y)-1.08%

Price vs S&P 500 (52W)-11.83%

P/E Ratio (TTM)22.28x

EPS Growth TTM (YoY)7.13%

Year-to-Date Return2.43%

5-Day Price Return2.38%

EPS Normalized (Annual)$3.27

ROA (5Y Avg)5.00%

Net Profit Margin (Annual)3.02%

Month-to-Date Return5.05%

Cash Flow / Share (TTM)$5.11

EBITD / Share (Annual)$7.75

EPS Growth (3Y)-5.69%

Operating Margin (Annual)4.95%

LT Debt / Equity (Annual)0.71x

P/CF (TTM)12.45x

ROI (5Y Avg)9.23%

P/E Excl Extra (TTM)22.28x

LT Debt / Equity (Quarterly)0.71x

EPS Basic Excl Extra (TTM)$3.27

P/TBV (Quarterly)4.04x

P/B Ratio (Annual)2.77x

Inventory Turnover (TTM)4.76x

Pretax Margin (TTM)4.04%

Book Value / Share (Annual)$28.03

Price vs S&P 500 (13W)1.01%

Net Margin Growth (5Y)-5.42%

Beta0.88x

P/FCF (Annual)17.02x

Revenue / Share (TTM)$111.40

ROE (TTM)11.92%

52-Week Low$61.95

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

3.61

3.70

3.77

Industry Peers — Medical & Hospital Equipment(1)

Symbol	P/E Ratio (Annual)	ROE (TTM)	Operating Margin (TTM)	Revenue Growth TTM (YoY)	Price
HSICHenry Schein Inc	22.28x	11.92%	4.95%	4.03%	$77.21
ACHAccendra Health, Inc.	—	-50.95%	0.17%	-55.89%	$3.33

About

Henry Schein is a healthcare solutions provider offering equipment, products, and services to dental and medical practitioners. The company generates primary revenue through Global Distribution and Value-Added Services, which supplies branded merchandise, equipment, and ancillary services including financial solutions and continuing education. Complementary revenues stem from Global Specialty Products and Global Technology segments serving both office-based and alternative care sites.